Absorption |
Blood-Brain Barrier | BBB+ | 0.9382 |
Human Intestinal Absorption | HIA+ | 0.9784 |
Caco-2 Permeability | Caco2+ | 0.7004 |
P-glycoprotein Substrate | Substrate | 0.9146 |
P-glycoprotein Inhibitor | Inhibitor | 0.5744 |
Inhibitor | 0.5786 |
Renal Organic Cation Transporter | Inhibitor | 0.5456 |
Distribution |
Subcellular localization | Mitochondria | 0.4630 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8333 |
CYP450 2D6 Substrate | Substrate | 0.8265 |
CYP450 3A4 Substrate | Substrate | 0.7756 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8816 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8585 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.6282 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7855 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.7875 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8723 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8131 |
Non-inhibitor | 0.6056 |
AMES Toxicity | Non AMES toxic | 0.7498 |
Carcinogens | Non-carcinogens | 0.9437 |
Fish Toxicity | High FHMT | 0.9714 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9692 |
Honey Bee Toxicity | High HBT | 0.5544 |
Biodegradation | Not ready biodegradable | 1.0000 |
Acute Oral Toxicity | III | 0.5958 |
Carcinogenicity (Three-class) | Non-required | 0.5934 |